| Net Cash Provided by (Used in) Operating Activities |
$193,854 |
USD |
-47% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$193,850 |
USD |
47% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
131,903,029 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$4 |
USD |
-33% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,612,000 |
USD |
10% |
Q4 2024 |
FY 2024 |
| Depreciation |
$125 |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$1,500 |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,612,000 |
USD |
10% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
2 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$10,187,703 |
USD |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
2 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |